Fidson Healthcare Signs Deal With Chinese Firm To Produce Drugs for Treatment of HIV

Fidson Healthcare Signs Deal With Chinese Firm To Produce Drugs for Treatment of HIV

  • Fidson Healthcare has reached a deal with its Jiangsu Aidea, a Chinese Pharmaceutica company, to produce HIV drugs in Nigeria
  • The two companies will also collaborate on project development to help address other medical challenges in the country
  • The Nigeria National HIV/AIDS Indicator and Impact Survey found that 1.9 million people are living with HIV and AIDS in Nigeria

Dave Ibemere has over a decade of experience covering Business and the Economy

Fidson Healthcare Plc (Fidson), a Nigerian company listed on the Nigeria Exchange, has signed a deal with Jiangsu Aidea Pharmaceutical Co. Ltd (Aidea Pharma) to produce HIV drugs.

The two companies hope that the deal will help address medical challenges through the use of innovative drugs, especially in the treatment of HIV-infected people in Nigeria.

HIV drugs in Nigeria
Fidson to start producing HIV drugs in Nigeria Photo credit: Luis Alvarez
Source: Getty Images

The deal was disclosed in a regulatory filing published on the Nigerian Exchange on Thursday, November 15, 2023.

Read also

After taking over Dubai-based assets, UBA to distribute $6bn loan to mechanics, farmers, other

Fidson to produce HIV drugs

Announcing the deal, Fidson said both companies agreed to share and combine their respective resources, technical expertise and positions in the market.

It also noted that there will be collaboration on project development, market expansion, and other aspects by integrating their competitive advantages in the pharmaceutical field.

At the signing ceremony, Dr. Heliang Fu, Chairman of Aidea Pharma, stated:

"This collaboration marks an important step for Aidea Pharma in its commitment to global medical cooperation.
By integrating our exper'tise and experience in the field of innovative drugs, we are confident in bringing greater well-being to African patients."

Also, Dr. Fidelis A. Ayebae, Managing Director and CEO of Fidson, noted:

"We are eagerly looking forward to this collaboration, and we believe that the complementary strengths of both parties will inject new vitality into the medical field in Africa. This is also in line with our commitment to provide better and more accessible medicines for the people of Africa.'"

Read also

Returning body of Nigerian medical student murdered in Philipines will cost N35m, FG says

Kano mass wedding: Surprise as intending couples test positive for HIV, pregnancy, others

In another report, some intending couples have tested positive for HIV, pregnancy and other sicknesses during pre-marital test screening.

The intending couples had to undergo the screening before partaking in the state-sponsored mass wedding in Kano.

The spokesperson of Hisbah Board, Lawan Fagge, said they had been replaced, subjected to counselling and given medications.


Dave Ibemere avatar

Dave Ibemere (Senior Business Editor) Dave Ibemere is a senior business editor at He is a financial journalist with over a decade of experience in print and online media. He also holds a Master's degree from the University of Lagos. He is a member of the African Academy for Open-Source Investigation (AAOSI), the Nigerian Institute of Public Relations and other media think tank groups. He previously worked with The Guardian, BusinessDay, and headed the business desk at Ripples Nigeria. Email:

Online view pixel